T Galbinur, E Averbukh, E Banin, I Hemo, I … - British Journal of Ophthalmology, 2009 - bjo.bmj.com Results: Mean lesion size was 3375 (SD 2116) μm, all lesions showed sub- or
intra-retinal fluid in OCT, and active neovascularisation comprised 41.6 (SD
17.7)% (range 10–90%) of the lesion area according to FA. The mean ... Related articles - All 3 versions
T Galbinur, E Averbukh, E Banin… - bjo.bmj.com Page 1. doi: 10.1136/bjo.2009.158931 published online June 10, 2009 Br J
Ophthalmol Tural Galbinur, Edward Averbukh, Eyal Banin, et al. ... Related articles
RA Cervantes-Castañeda, E Banin, I Hemo, M … - Eye, 2007 - nature.com A retrospective analysis of 268 eyes of 268 consecutive patients with newly
diagnosed NVAMD that were treated in a tertiary referral centre was performed.
Patients were classified into those who were unaware (Group 1), or aware ... Cited by 5 - Related articles - All 3 versions
- ►prsjournal.com R EHRLICH, DOV WEINBERGER, E PRIEL, … - Retina, 2008 - journals.lww.com From the *Department of Ophthalmology, Rabin Medical Center, Beilinson Campus,
Petah Tiqwa; †Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; and
‡Mor Institute for Medical Data, Bnei Brak, Israel. Cited by 6 - Related articles - All 5 versions
JI Lim - jhasio.com Over the past decade, treatment of neovascular age-related macular degeneration
has evolved from overall retinal ablation to more targeted and retinal-sparing
therapy, beginning with the advent of photodynamic therapy and continuing ... Related articles
A DeWan, MB Bracken, J Hoh - Current opinion in genetics & development, 2007 - Elsevier The discovery of strong associations of the His402 variant of complement factor
H (CFH) and the change in the promoter region of HtrA serine peptidase 1 (HTRA1)
with age-related macular degeneration (AMD) have altered our conception of ... Cited by 10 - Related articles - All 4 versions
JL Prenner, R Kaiser, TS Chang - Ophthalmology, 2009 - Elsevier Anti-vascular endothelial growth factor (VEGF) therapies have fundamentally
changed the treatment of choroidal neovascularization (CNV) secondary to
neovascular age-related macular degeneration (AMD). The results of ANCHOR ( ... Related articles - All 13 versions
S de Farmacia - chospab.es El Dr.Juan Lopez Moya, Jefe de Servicio de Oftalmología solicita Lucentis®
(Ranibizumab) como tratamiento de elección en las membranas neovasculares
subretinianas de la Degeneración Macular Asociada a la Edad (DAME) húmeda. Related articles - View as HTML
- ►prsjournal.com DY Rhee - Evidence-Based Ophthalmology, 2008 - journals.lww.com Research Objective To evaluate fluorescein angiographic and visual acuity (VA)
outcomes from pa- tients enrolled in a trial of a single periocular
corticosteroid injection im- mediately before photodynamic therapy (PDT) ... Related articles - BL Direct - All 2 versions
